Please assess the completion status of the following clinical trial:

Trial Title: DDI Between BI Empagliflozin (10773) and Verapamil

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~healthy male and female subjects~Exclusion criteria:~Any relevant deviation from healthy conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Reference (Type: EXPERIMENTAL): single dose BI 10773
- Test (Type: ACTIVE_COMPARATOR): single dose BI 10773 + single dose verapamil

Based on this trial design, predict the completion outcome and termination type (if applicable).